Wild Panax Ginseng (Panax ginsengC.A. Meyer) Protects Against Methotrexate–Induced Cell Regression by Enhancing the Immune Response in RAW 264.7 Macrophages

American Journal of Chinese Medicine - Tập 38 Số 05 - Trang 949-960 - 2010
Hyo Il Jang1, Heung‐Mook Shin1
1College of Oriental Medicine, Dongguk University, Gyeongju 780-714, South Korea

Tóm tắt

Many traditional herbal medicines have been re-evaluated to determine whether they enhance immune responses. In this study, the possible use of wild Panax ginseng (WPG) for enhancement of host immunity in chemotherapy was investigated. In the cell proliferation assay, WPG significantly enhanced the proliferation of RAW 264.7 macrophages and protected against cell regression in macrophages treated with methotrexate (MTX). WPG induced the production of nitric oxide and the expression of inducible nitric oxide synthase and cyclooxygense-2 mRNA. Furthermore, WPG enhanced the production of cytokines including interleukin (IL)-1α, IL-1β, IL-6, tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor, and chemokines such as macrophage chemotactic protein-1 and regulated upon activation, normal T-cell expressed and secreted (RANTES), regardless of MTX co-administration. Taken together, these results provide the first evidence that WPG triggers immune responses through the prevention of macrophage cell regression caused by MTX and functional activation of macrophages.

Từ khóa


Tài liệu tham khảo

10.1016/S0049-0172(95)80009-3

10.1142/S0192415X94000176

10.1016/0192-0561(88)90025-2

10.1126/science.106.2764.619

10.1172/JCI2676

Gorilick R., New Engl. J. Med., 335, 1041, 10.1056/NEJM199610033351408

Green S. J., J. Immunol., 144, 278, 10.4049/jimmunol.144.1.278

10.1016/j.jep.2007.05.014

10.1126/science.2432665

Hu S. K., J. Rheumatol., 5, 206

10.1046/j.1537-2995.2002.00249.x

10.1016/0065-2571(94)90025-6

10.1073/pnas.84.18.6369

Jun S. Y., Oncol. Rep., 15, 1461

10.1016/S0889-857X(05)70368-9

Kim S. J., Kor. J. Herbol., 19, 41

M. S. Kopreski, Cancer Chemotherapy and Biotherapy, 2nd edn., eds. B. A. Chabner and D. L. Long (Lippincott-Raven, Philadelphia, 1996) pp. 765–785.

10.1002/art.20278

Lee Y. S., Anticancer Res., 17, 323

10.1016/j.jep.2007.02.026

Liu C. X., J. Ethnopharmacol., 36, 27

Mauel J., J. Leukocyte Biol., 58, 217, 10.1002/jlb.58.2.217

10.1006/bbrc.1994.1644

10.1046/j.1523-5394.2002.103004.x

10.1007/s10238-001-8025-0

10.1016/S0165-2478(00)00247-9

10.1080/13684730310000923

Riese J., J. Leukocyte Biol., 55, 476, 10.1002/jlb.55.4.476

10.1002/cncr.20883

H. Stevenson and K. Y. Tsang, Introduction to Medical Immunology, 3rd edn., ed. G. Virella (Marcel Dekker, New York, 1993) pp. 497–515.

10.1021/bk-1998-0691.ch016

10.1142/S0192415X02000661

10.1007/978-3-642-73739-8

10.3346/jkms.2001.16.S.S19